Vantage Financial Partners Ltd., Inc. Pfizer Inc Transaction History

Vantage Financial Partners Ltd., Inc.

$394 Million
Q2 2024

A detailed history of Vantage Financial Partners Ltd., Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Vantage Financial Partners Ltd., Inc. holds 17,696 shares of PFE stock, worth $472,837. This represents 0.13% of its overall portfolio holdings.

Number of Shares

17,696

Previous 19,086 7.28%

Holding current value

$472,837

Previous $529,000 6.43%

% of portfolio

0.13%

Previous 0.14%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$25.26 - $29.6 $35,111 - $41,144	-1,390 Reduced 7.28%	17,696 $495,000
Q1 2024 May 14, 2024	SELL	$25.89 - $29.73 $125,928 - $144,606	-4,864 Reduced 20.31%	19,086 $529,000
Q4 2023 Feb 13, 2024	SELL	$26.13 - $33.94 $130,650 - $169,700	-5,000 Reduced 17.27%	23,950 $689,000
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $16,045 - $18,755	500 Added 1.76%	28,950 $960,000
Q2 2023 Aug 08, 2023	BUY	$36.12 - $41.79 $32,507 - $37,611	900 Added 3.27%	28,450 $1.04 Million
Q1 2023 May 04, 2023	BUY	$39.39 - $51.28 $55,146 - $71,792	1,400 Added 5.35%	27,550 $1.12 Million
Q4 2022 Feb 07, 2023	BUY	$41.75 - $54.5 $50,100 - $65,400	1,200 Added 4.81%	26,150 $1.34 Million
Q3 2022 Nov 09, 2022	BUY	$43.76 - $53.42 $78,768 - $96,156	1,800 Added 7.78%	24,950 $1.09 Million
Q2 2022 Aug 08, 2022	BUY	$46.53 - $55.17 $418,770 - $496,530	9,000 Added 63.6%	23,150 $1.21 Million
Q1 2022 May 02, 2022	BUY	$45.75 - $56.69 $43,462 - $53,855	950 Added 7.2%	14,150 $732,000
Q4 2021 Jan 27, 2022	BUY	$41.32 - $61.25 $26,858 - $39,812	650 Added 5.18%	13,200 $779,000
Q3 2021 Nov 05, 2021	BUY	$39.25 - $50.42 $51,025 - $65,546	1,300 Added 11.56%	12,550 $540,000
Q2 2021 Aug 11, 2021	BUY	$35.91 - $40.68 $39,500 - $44,748	1,100 Added 10.84%	11,250 $441,000
Q1 2021 May 05, 2021	BUY	$33.49 - $37.77 $30,141 - $33,993	900 Added 9.73%	10,150 $368,000
Q4 2020 Feb 05, 2021	SELL	$33.47 - $42.56 $7,530 - $9,576	-225 Reduced 2.37%	9,250 $340,000
Q2 2019 Aug 08, 2019	SELL	$36.98 - $41.52 $19,969 - $22,420	-540 Reduced 5.39%	9,475 $0
Q3 2018 Nov 02, 2018	SELL	$34.47 - $41.81 $162,009 - $196,507	-4,700 Reduced 31.94%	10,015 $441,000
Q2 2018 Aug 09, 2018	BUY	$32.98 - $35.16 $3,297 - $3,515	100 Added 0.68%	14,715 $534,000
Q1 2018 May 07, 2018	SELL	$31.91 - $37.02 $51,056 - $59,232	-1,600 Reduced 9.87%	14,615 $519,000
Q4 2017 Feb 09, 2018	SELL	$33.26 - $35.29 $136,366 - $144,689	-4,100 Reduced 20.18%	16,215 $588,000
Q3 2017 Nov 02, 2017	SELL	$31.0 - $34.15 $40,300 - $44,395	-1,300 Reduced 6.01%	20,315 $726,000
Q2 2017 Aug 14, 2017	BUY	N/A	20,890 Added 2881.38%	21,615 $725,000
Q2 2017 Aug 10, 2017	BUY	N/A	725	725 $725,000

Others Institutions Holding PFE

# of Institutions

3,271

Shares Held

3.63B

Call Options Held

74.3M

Put Options Held

107M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vantage Financial Partners Ltd., Inc., based on Form 13F filings with the SEC.

News

Stay updated on Vantage Financial Partners Ltd., Inc. with notifications on news.

Account

Vantage Financial Partners Ltd., Inc. Pfizer Inc Transaction History